Conference Proceedings

Baseline characteristics and interim analysis results of TRANSITION: a 2-year observational study evaluating the safety profile of patients with multiple sclerosis who switched from natalizumab to fingolimod

H Butzkueven, B Weller, PS Giacomini, S Cohan, T Ziemssen, D Tomic, E Verdun Di Cantogno, T Faivre, T Sett, M Trojano

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2015